PMV Pharmaceuticals is a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies that target p53 mutations
PMV Pharmaceuticals is a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies that target p53 mutations. The company focuses on restoring the tumor suppressing function of mutated p53 proteins, which are implicated in approximately half of all human cancers.
The top three firms on F4's Biotech & Life Sciences investor list.